Exact Sciences - EXAS Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $97.44
Forecasted Upside: 65.57%
Number of Analysts: 14
Breakdown:
0 Sell Ratings
2 Hold Ratings
12 Buy Ratings
0 Strong Buy Ratings

^$58.85 As of 04/26/2024 01:00 AM ET

▲ +0.06 (0.10%)

1 month | 3 months | 12 months

Get New Exact Sciences Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for EXAS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EXAS

^$97.44

▲ +65.57% Upside Potential

This price target is based on 14 analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $97.44, with a high forecast of $121.00 and a low forecast of $73.00. The average price target represents a 65.57% upside from the last price of $58.85.

Current Consensus is Moderate Buy

The current consensus among 14 contributing investment analysts is to moderate buy stock in Exact Sciences. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

11/4/2022

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/2/2023

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/3/2023

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

8/1/2023

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

10/30/2023

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

1/28/2024

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/28/2024

0 strong buy ratings
12 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/27/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/3/2024	Citigroup	Reiterated Rating	Buy ➝ Buy	$100.00	Low
2/22/2024	Canaccord Genuity Group	Lower Target	Buy ➝ Buy	$100.00 ➝ $90.00	Low
2/22/2024	William Blair	Reiterated Rating	Outperform		Low
1/8/2024	William Blair	Reiterated Rating	Outperform		Low
1/2/2024	Benchmark	Upgrade	Hold ➝ Buy	$91.00	Low
12/14/2023	Guggenheim	Initiated Coverage	Buy	$90.00	Low
12/13/2023	Wolfe Research	Initiated Coverage	Outperform	$95.00	Low
11/3/2023	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$100.00 ➝ $90.00	Low
11/2/2023	William Blair	Reiterated Rating	Outperform		Low
10/16/2023	Piper Sandler	Lower Target	Overweight ➝ Overweight	$90.00 ➝ $80.00	Low
10/10/2023	Piper Sandler	Upgrade	Neutral ➝ Overweight	$90.00	Low
9/28/2023	Sanford C. Bernstein	Initiated Coverage	Outperform	$83.00	Low
8/8/2023	Piper Sandler	Boost Target	Neutral ➝ Neutral	$80.00 ➝ $90.00	Low
8/3/2023	Jefferies Financial Group	Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	Low
8/2/2023	Bank of America	Boost Target		$105.00 ➝ $110.00	Low
8/2/2023	Credit Suisse Group	Boost Target	Neutral ➝ Neutral	$75.00 ➝ $90.00	Low
8/2/2023	Robert W. Baird	Boost Target	Outperform ➝ Outperform	$99.00 ➝ $121.00	Low
8/2/2023	Benchmark	Downgrade	Buy ➝ Hold		Low
7/21/2023	The Goldman Sachs Group	Boost Target	Buy	$85.00 ➝ $110.00	Low
6/22/2023	Stifel Nicolaus	Boost Target		$85.00 ➝ $120.00	Low
6/22/2023	Craig Hallum	Boost Target		$85.00 ➝ $106.00	Low
6/22/2023	BTIG Research	Boost Target		$95.00 ➝ $110.00	Low
6/22/2023	Citigroup	Boost Target		$100.00 ➝ $130.00	Low
6/22/2023	Benchmark	Boost Target		$81.00 ➝ $96.00	Low
6/7/2023	Jefferies Financial Group	Boost Target		$82.00 ➝ $100.00	Low
5/15/2023	Piper Sandler	Boost Target		$70.00 ➝ $80.00	Low
5/11/2023	Citigroup	Boost Target		$90.00 ➝ $100.00	Low
5/10/2023	Stifel Nicolaus	Boost Target		$75.00 ➝ $85.00	Low
5/10/2023	BTIG Research	Boost Target		$80.00 ➝ $90.00	Low
5/10/2023	Bank of America	Boost Target		$80.00 ➝ $88.00	Low
5/10/2023	Robert W. Baird	Boost Target		$92.00 ➝ $99.00	Low
5/10/2023	Craig Hallum	Upgrade	Hold ➝ Buy	$55.00 ➝ $85.00	N/A
5/5/2023	UBS Group	Initiated Coverage	Neutral	$73.00	Low
3/15/2023	Benchmark	Boost Target	Buy	$54.00 ➝ $78.00	Low
3/9/2023	Citigroup	Upgrade	Neutral ➝ Buy	$70.00 ➝ $90.00	Low
3/3/2023	Piper Sandler	Boost Target	Neutral	$50.00 ➝ $70.00	Low
2/22/2023	Craig Hallum	Boost Target		$44.00 ➝ $55.00	Low
2/22/2023	Canaccord Genuity Group	Boost Target	Buy	$70.00 ➝ $75.00	Low
2/22/2023	Cowen	Boost Target	Outperform	$56.00 ➝ $76.00	Low
2/22/2023	Robert W. Baird	Boost Target	Outperform	$89.00 ➝ $92.00	Low
2/22/2023	BTIG Research	Lower Target	Buy	$85.00 ➝ $80.00	Low
2/22/2023	Credit Suisse Group	Reiterated Rating	Neutral	$70.00	Low
2/22/2023	Citigroup	Boost Target	Neutral	$35.00 ➝ $70.00	Low
2/10/2023	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$50.00 ➝ $70.00	Low
1/18/2023	Raymond James	Downgrade	Outperform ➝ Market Perform		Low
1/12/2023	SVB Leerink	Boost Target	Outperform	$70.00 ➝ $75.00	Low
1/9/2023	Craig Hallum	Boost Target		$35.00 ➝ $44.00	Low
1/6/2023	SVB Leerink	Boost Target	Outperform	$60.00 ➝ $70.00	Low
11/14/2022	Piper Sandler	Boost Target	Neutral	$40.00 ➝ $50.00	Low
11/7/2022	Raymond James	Lower Target	Outperform	$70.00 ➝ $60.00	Low
11/7/2022	BTIG Research	Lower Target	Buy	$70.00 ➝ $65.00	Low
11/4/2022	Robert W. Baird	Lower Target		$75.00 ➝ $60.00	Low
11/4/2022	Citigroup	Lower Target		$50.00 ➝ $35.00	Low
10/19/2022	Craig Hallum	Downgrade	Buy ➝ Hold	$60.00 ➝ $35.00	Low
8/24/2022	Credit Suisse Group	Initiated Coverage	Outperform	$55.00	Low
8/17/2022	Piper Sandler	Lower Target	Overweight	$50.00 ➝ $40.00	Low
8/9/2022	Evercore ISI	Boost Target		$65.00	N/A
8/9/2022	Benchmark	Lower Target		$54.00	N/A
8/3/2022	Raymond James	Lower Target	Outperform	$80.00 ➝ $70.00	Low
8/3/2022	Citigroup	Lower Target	Neutral	$65.00 ➝ $50.00	Low
8/3/2022	Robert W. Baird	Lower Target	Outperform	$90.00 ➝ $75.00	Low
8/3/2022	BTIG Research	Lower Target	Buy	$100.00 ➝ $70.00	Low
8/3/2022	Cowen	Lower Target	Outperform	$83.00 ➝ $67.00	N/A
8/3/2022	Cowen	Lower Target	Outperform	$83.00 ➝ $67.00	Low
8/3/2022	Craig Hallum	Lower Target	Buy	$81.00 ➝ $60.00	Low
7/19/2022	Cowen	Set Target		$83.00	Low
6/2/2022	Piper Sandler	Initiated Coverage	Neutral	$50.00	High
4/27/2022	Craig Hallum	Lower Target		$100.00 ➝ $81.00	Low
4/27/2022	Robert W. Baird	Lower Target		$100.00 ➝ $90.00	High
4/27/2022	Raymond James	Lower Target		$90.00 ➝ $80.00	High
4/27/2022	Citigroup	Lower Target		$80.00 ➝ $65.00	High
4/19/2022	The Goldman Sachs Group	Lower Target	Buy	$100.00 ➝ $85.00	Low
2/23/2022	Craig Hallum	Lower Target		$133.00 ➝ $100.00	High
2/23/2022	Raymond James	Lower Target	Outperform	$130.00 ➝ $90.00	High
2/23/2022	Wells Fargo & Company	Lower Target	Equal Weight	$95.00 ➝ $80.00	High
2/23/2022	Robert W. Baird	Lower Target		$116.00 ➝ $100.00	High
2/23/2022	Citigroup	Lower Target	Neutral	$100.00 ➝ $80.00	High
2/23/2022	SVB Leerink	Lower Target	Outperform	$140.00 ➝ $130.00	High
11/3/2021	BTIG Research	Lower Target	Positive ➝ Buy	$145.00 ➝ $120.00	High
11/3/2021	Craig Hallum	Lower Target	Buy	$144.00 ➝ $133.00	High
11/3/2021	SVB Leerink	Lower Target	Outperform	$160.00 ➝ $140.00	High
11/3/2021	Wells Fargo & Company	Lower Target	Equal Weight	$120.00 ➝ $95.00	High
11/3/2021	Robert W. Baird	Lower Target	Outperform	$125.00 ➝ $116.00	High
11/3/2021	Raymond James	Downgrade	Strong-Buy ➝ Outperform	$160.00 ➝ $130.00	High
10/14/2021	Cowen	Lower Target	Outperform	$160.00 ➝ $135.00	Low
7/29/2021	Stifel Nicolaus	Lower Target	Buy	$165.00 ➝ $145.00	High
7/29/2021	BTIG Research	Lower Target	Buy	$155.00 ➝ $145.00	High
7/29/2021	Oppenheimer	Lower Target	Outperform	$161.00 ➝ $155.00	High
7/29/2021	Robert W. Baird	Lower Target	Outperform	$157.00 ➝ $127.00	High
7/14/2021	SVB Leerink	Lower Target	Outperform	$170.00 ➝ $160.00	High
6/21/2021	Wells Fargo & Company	Boost Target	Equal Weight	$115.00 ➝ $120.00	Low
6/15/2021	Raymond James	Initiated Coverage	Strong-Buy	$160.00	Medium
6/3/2021	The Goldman Sachs Group	Initiated Coverage	Buy	$160.00	Low
5/25/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$115.00	Low
5/12/2021	Truist Financial	Lower Target	Buy	$226.00 ➝ $168.00	Medium
5/5/2021	Craig Hallum	Lower Target	Buy	$161.00 ➝ $144.00	High
5/5/2021	BTIG Research	Lower Target	Buy	$175.00 ➝ $155.00	High
5/5/2021	SVB Leerink	Lower Target	Outperform	$180.00 ➝ $170.00	High
2/18/2021	Robert W. Baird	Lower Target	Outperform	$169.00 ➝ $163.00	Low
2/17/2021	Stifel Nicolaus	Boost Target	Buy	$150.00 ➝ $165.00	Low
2/17/2021	SVB Leerink	Boost Target	Market Perform ➝ Outperform	$170.00 ➝ $180.00	Low
2/17/2021	Cowen	Boost Target	Outperform	$154.00 ➝ $180.00	Low
1/27/2021	Truist Financial	Initiated Coverage	Buy	$226.00 ➝ $226.00	Medium
1/21/2021	SVB Leerink	Boost Target	Outperform	$160.00 ➝ $170.00	Medium
10/29/2020	UBS Group	Downgrade	Buy ➝ Neutral	$125.00 ➝ $140.00	High
10/28/2020	Oppenheimer	Boost Target		$115.00 ➝ $150.00	Low
10/28/2020	BTIG Research	Boost Target		$140.00 ➝ $155.00	Low
10/28/2020	Smith Barney Citigroup	Downgrade	Buy ➝ Neutral	$120.00 ➝ $140.00	Low
10/28/2020	Robert W. Baird	Boost Target	Positive ➝ Outperform	$135.00 ➝ $150.00	Low
10/28/2020	SVB Leerink	Boost Target	Outperform	$115.00 ➝ $160.00	Low
10/28/2020	Benchmark	Boost Target	Buy	$110.00 ➝ $145.00	Low
7/31/2020	SVB Leerink	Boost Target	Outperform	$90.00 ➝ $115.00	High
7/31/2020	Benchmark	Boost Target	Buy	$90.00 ➝ $110.00	Low
7/31/2020	Citigroup	Boost Target	Buy	$110.00 ➝ $120.00	Low
7/8/2020	Oppenheimer	Reiterated Rating	Buy		High
6/25/2020	Citigroup	Boost Target	Buy	$100.00 ➝ $110.00	Medium
5/7/2020	Robert W. Baird	Boost Target	Outperform	$90.00 ➝ $92.00	Low
5/7/2020	Bank of America	Boost Target	Buy	$88.00 ➝ $94.00	Low
5/7/2020	Craig Hallum	Lower Target	In-Line ➝ Buy	$99.00 ➝ $92.00	Low
5/7/2020	SVB Leerink	Lower Target	Outperform	$100.00 ➝ $90.00	High
4/28/2020	UBS Group	Lower Target	Buy	$135.00 ➝ $115.00	High
4/22/2020	Citigroup	Lower Target	Buy	$120.00 ➝ $100.00	Medium
4/22/2020	Robert W. Baird	Lower Target	Outperform	$100.00 ➝ $90.00	High
4/21/2020	Oppenheimer	Reiterated Rating	Buy	$115.00	Low
4/17/2020	Craig Hallum	Lower Target	Buy	$127.00 ➝ $99.00	High
4/2/2020	Stifel Nicolaus	Lower Target	Buy	$110.00 ➝ $90.00	Low
4/2/2020	Evercore ISI	Initiated Coverage	Outperform	$70.00	High
2/14/2020	Stifel Nicolaus	Reiterated Rating	Buy	$110.00	N/A
2/12/2020	Robert W. Baird	Reiterated Rating	Buy		Low
1/10/2020	BTIG Research	Initiated Coverage	Buy	$127.00	High
1/6/2020	Citigroup	Initiated Coverage	Buy	$120.00	Low
12/13/2019	Dougherty & Co	Initiated Coverage	Buy	$120.00	Low
11/14/2019	Stifel Nicolaus	Initiated Coverage	Buy	$110.00	High
10/31/2019	Bank of America	Reiterated Rating	Buy	$135.00	Medium
10/30/2019	SVB Leerink	Lower Target	Outperform	$133.00 ➝ $105.00	Medium
10/30/2019	Jefferies Financial Group	Lower Target	Buy	$138.00 ➝ $120.00	High
10/17/2019	Bank of America	Boost Target	Buy	$130.00 ➝ $135.00	Low
9/26/2019	Oppenheimer	Initiated Coverage	Outperform	$130.00	Medium
9/24/2019	SVB Leerink	Reiterated Rating	Buy		High
9/23/2019	Benchmark	Upgrade	Hold ➝ Buy	$130.00	High
9/10/2019	William Blair	Reiterated Rating	Buy		Low
8/1/2019	UBS Group	Boost Target	Buy	$120.00 ➝ $143.00	Low
7/30/2019	Craig Hallum	Boost Target	Buy	$115.00 ➝ $127.00	Medium
7/29/2019	Cowen	Boost Target	Outperform	$125.00 ➝ $135.00	Low
5/1/2019	Jefferies Financial Group	Boost Target	Buy	$100.00 ➝ $115.00	Low
5/1/2019	UBS Group	Boost Target	Buy ➝ Buy	$115.00 ➝ $120.00	Low
5/1/2019	Craig Hallum	Reiterated Rating	Buy	$95.00 ➝ $115.00	Low
5/1/2019	BTIG Research	Boost Target	Buy	$130.00	Low

(Data available from 4/27/2019 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

15 very positive mentions
6 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

9/30/2023

11 very positive mentions
9 positive mentions
6 negative mentions
2 very negative mentions

Mentions as of

10/30/2023

2 very positive mentions
13 positive mentions
1 negative mentions
3 very negative mentions

Mentions as of

11/29/2023

14 very positive mentions
11 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

12/29/2023

19 very positive mentions
8 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

1/28/2024

23 very positive mentions
22 positive mentions
4 negative mentions
2 very negative mentions

Mentions as of

2/27/2024

15 very positive mentions
14 positive mentions
1 negative mentions
1 very negative mentions

Mentions as of

3/28/2024

17 very positive mentions
13 positive mentions
4 negative mentions
3 very negative mentions

Mentions as of

4/27/2024

Current Sentiment

Recent Stories by Sentiment

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $58.85

$58.45

$60.31

50 Day Range

MA: $63.44

$56.27

$74.26

52 Week Range

Now: $58.85

$56.05

$100.77

Volume

2,018,885 shs

Average Volume

2,286,792 shs

Market Capitalization

$10.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Frequently Asked Questions

What sell-side analysts currently cover shares of Exact Sciences?: The following Wall Street analysts have issued reports on Exact Sciences in the last year: Bank of America Co., Benchmark Co., BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Craig Hallum, Credit Suisse Group AG, Guggenheim, Jefferies Financial Group Inc., Piper Sandler, Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, William Blair, and Wolfe Research.
View the latest analyst ratings for EXAS.
What is the current price target for Exact Sciences?: 16 Wall Street analysts have set twelve-month price targets for Exact Sciences in the last year. Their average twelve-month price target is $97.44, suggesting a possible upside of 65.6%. Robert W. Baird has the highest price target set, predicting EXAS will reach $121.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $73.00 for Exact Sciences in the next year.
View the latest price targets for EXAS.
What is the current consensus analyst rating for Exact Sciences?: Exact Sciences currently has 2 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for EXAS.
What other companies compete with Exact Sciences?: Other companies that are similar to Exact Sciences include Natera, PRA Health Sciences, Exelixis, PPD and Laboratory Co. of America. Learn More about companies similar to Exact Sciences.
How do I contact Exact Sciences' investor relations team?: Exact Sciences' physical mailing address is 5505 ENDEAVOR LANE, MADISON WI, 53719. The medical research company's listed phone number is (608) 284-5700 and its investor relations email address is [email protected]. The official website for Exact Sciences is www.exactsciences.com. Learn More about contacing Exact Sciences investor relations.

Exact Sciences - EXAS Stock Price Target and Predictions

Analyst Price Target for EXAS

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.56 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Exact Sciences?

What is the current price target for Exact Sciences?

What is the current consensus analyst rating for Exact Sciences?

What other companies compete with Exact Sciences?

How do I contact Exact Sciences' investor relations team?